An Interview with Gerd Maass, VP for R&D at Roche Pharmaceuticals: Chapter 1 - DNA Sequencing

Gerd Maass, Vice President for R&D at Roche Pharmaceuticals, shares his views on advances in companion diagnostics, DNA sequencing and biobanking. This segment on DNA sequencing addresses claims that use of DNA sequencing systems in labs has been increasing for the past few years to about 80% of laboratories.

In response, Maass pinpoints how heavily Roche depends on sequencing technology. He also discusses the recent improvements to sample preparation and library preparation systems to accommodate the volume of data. Next he predicts the impact of technological advances on the cost of DNA Sequencing and, in turn, the future of healthcare. Finally, he talks about new methods of interpreting and utilising DNA sequenced data at Roche to turn data into usable knowledge.